Germline Homozygous Mutations at Codon 804 in the<i>RET</i>Protooncogene in Medullary Thyroid Carcinoma/Multiple Endocrine Neoplasia Type 2A Patients
Fabienne Lesueur(Inserm), B. A. J. Ponder, Mercedes Robledo(The University of Texas at San Antonio Health Science Center), T. M. Faid(Halesowen College), Arancha Cebrián(Hospital Universitario Fundación Jiménez Díaz), M. R. Clements(Manchester Royal Infirmary), John C. Whittaker(University of Cambridge), Jean Leyland(University of Cambridge), Aaron Cranston(AstraZeneca (United Kingdom))
Cited by 50
Related Papers
The support of human genetic evidence for approved drug indications
|Nature Genetics|2015|1.8k
Localization of the gene for Cowden disease to chromosome 10q22–23
|Nature Genetics|1996|670
Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma
|Nature Genetics|2011|528
Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension
|Journal of Hypertension|2020|406
Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas
|Human Molecular Genetics|2013|394